Fulfilling the Needs of Multiple Stakeholders for Biopharmaceutical Product Success - A Conversation with Charles A Stevens.
- Published in:
- 2010
- By:
- Publication type:
- Interview
Works matching IS 20458894 AND DT 2010 AND VI 5
Results: 15
1
2
Exploring the Future of the Pharmaceutical Industry and the Healthcare System - The Benefits of Electronic Health Records Becoming a Reality.
- Published in:
- Drug Development, 2010, v. 5, p. 58
- By:
- Publication type:
- Article
3
Understanding the US Food and Drug Administration's May 2007 Guidance - 'Computerized Systems Used in Clinical Investigations'.
- Published in:
- Drug Development, 2010, v. 5, p. 56
- By:
- Publication type:
- Article
4
The Growing Complexity of Clinical Trials Requires a Software-as-a-Service-based Approach to Document Exchange.
- Published in:
- Drug Development, 2010, v. 5, p. 50
- By:
- Publication type:
- Article
5
Outsourcing in Drug Development.
- Published in:
- Drug Development, 2010, v. 5, p. 48
- By:
- Publication type:
- Article
6
Data Management Systems versus Data Warehousing - What Really Matters.
- Published in:
- Drug Development, 2010, v. 5, p. 44
- By:
- Publication type:
- Article
7
The Benefits and Risks of Using Positron Emission Tomography in Clinical Drug Development.
- Published in:
- Drug Development, 2010, v. 5, p. 37
- By:
- Publication type:
- Article
8
Botanical Drug Development - How Natural Health Products Can Become Drugs.
- Published in:
- Drug Development, 2010, v. 5, p. 34
- By:
- Publication type:
- Article
9
Non-clinical Assessment of New Drug Products.
- Published in:
- Drug Development, 2010, v. 5, p. 30
- By:
- Publication type:
- Article
10
A Prescription for Industry - Risk Evaluation and Mitigation Strategy and Safety as a Paradigm.
- Published in:
- Drug Development, 2010, v. 5, p. 26
- By:
- Publication type:
- Article
11
The Efficacy of Patient and Healthcare Provider Communication Tools as Risk Mitigation Strategies.
- Published in:
- Drug Development, 2010, v. 5, p. 21
- By:
- Publication type:
- Article
12
The 'New Normal' of Regulatory Oversight of Clinical Investigators.
- Published in:
- Drug Development, 2010, v. 5, p. 16
- By:
- Publication type:
- Article
13
Pharmacovigilance in the 'New Pharma'.
- Published in:
- Drug Development, 2010, v. 5, p. 12
- By:
- Publication type:
- Article
14
Clinical Trial Safety - The Goldilocks Dilemma - Balancing Effective and Efficient Safety Monitoring.
- Published in:
- Drug Development, 2010, v. 5, p. 8
- By:
- Publication type:
- Article
15
Foreword.
- Published in:
- Drug Development, 2010, v. 5, p. 6
- By:
- Publication type:
- Article